Regulation and deregulation of G2 checkpoint proteins with cisplatin

Citation
M. Links et al., Regulation and deregulation of G2 checkpoint proteins with cisplatin, ANTICANC R, 18(6A), 1998, pp. 4057-4066
Citations number
17
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTICANCER RESEARCH
ISSN journal
02507005 → ACNP
Volume
18
Issue
6A
Year of publication
1998
Pages
4057 - 4066
Database
ISI
SICI code
0250-7005(199811/12)18:6A<4057:RADOGC>2.0.ZU;2-R
Abstract
Background. The G2 checkpoint has a key role in the response to DNA damage. G2 arrest following DNA damage is associated with inactivation of the prot ein kinase cyclin B-cdc2. The role of changes in protein expression in enzy me inhibition is controversial. Methods. Expression of cyclin B1, cdc2, cdc 25c, total protein and DNA content were examined by flow cytometry in two l ung cancer cell lines. Changes in protein expression were compared to cell cycle matched controls under conditions associated with and without G2 arre st Results. Total protein increased with G2 arrest and decreased with cell death. Changes in cdc2, cdc25c and p16 paralleled changes in total protein. A larger increase in cyclin B1 was seen which was due to cell cycle redist ribution. Deregulation of cyclin B1 was seen with a sublethal dose of cispl atin. Conclusions. Our results do not support the model that changes in exp ression of cyclin B1 or other checkpoint proteins mediate G2 arrest after c isplatin.